Fmoc-L-Tyr(Propargyl)-OH

Nom chimique: N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-propargyl-L-tyrosine // Synonymes: Fmoc-Tyr(Propargyl)-OH, Fmoc-Tyr(Propargyl), N-Fmoc-O-2-propyn-1-yl-L-tyrosine, (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(prop-2-yn-1-yloxy)phenyl)propanoic acid

n° Art.:FAA3830
n° CAS:1204595-05-0
Formule:C₂₇H₂₃NO₅
Storage temperature:2-8°C
Masse moléculaire:441,48 g/mol

from 225,00 €

Grouped product items
Nombre	Unité de vente	Prix	SKU	Disponibilité
	1 g	225,00 €	FAA3830.0001	<10 jour ouvrables
	5 g	850,00 €	FAA3830.0005	<10 jour ouvrables
	25 g	2 400,00 €	FAA3830.0025	sur demande
Fiches de données de sécurité

Skip to the end of the images gallery

Skip to the beginning of the images gallery

references

Neoglycopeptides through direct functionalization of cysteine; C. Vala, F. Chrétien, E. Balentova, S. Lamandé-Langle and Y. Chapleur; Tetrahedron Letters 2011; 52: 17-20. https://doi.org/10.1016/j.tetlet.2010.10.021

Photoinduced addition of glycosyl thiols to alkynyl peptides: use of free-radical thiol-yne coupling for post-translational double-glycosylation of peptides; M. Lo Conte, S. Pacifico, A. Chambery, A. Marra and A. Dondoni; J Org Chem 2010; 75: 4644-7. https://doi.org/10.1021/jo1008178

Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors; K. D. Park, P. Morieux, C. Salome, S. W. Cotten, O. Reamtong, C. Eyers, S. J. Gaskell, J. P. Stables, R. Liu and H. Kohn; Journal of medicinal chemistry 2009; 52: 6897-911. https://doi.org/10.1021/jm9012054

On the function and structure of synthetically modified porins; S. Reitz, M. Cebi, P. Reiss, G. Studnik, U. Linne, U. Koert and L. O. Essen; Angew Chem Int Ed Engl 2009; 48: 4853-7. https://doi.org/10.1002/anie.200900457

Non-enzymatic covalent protein labeling using a reactive tag; H. Nonaka, S. Tsukiji, A. Ojida and I. Hamachi; J Am Chem Soc 2007; 129: 15777-9. https://doi.org/10.1021/ja074176d

Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation; Z. L. Wei, P. A. Petukhov, F. Bizik, J. C. Teixeira, M. Mercola, E. A. Volpe, R. I. Glazer, T. M. Willson and A. P. Kozikowski; J Am Chem Soc 2004; 126: 16714-5. https://doi.org/10.1021/ja046386l

The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity; B. A. Seigal, W. H. Connors, A. Fraley, R. M. Borzilleri, P. H. Carter, S. L. Emanuel, J. Fragnoli, K. Kim, M. Lei, J. G. Naglich, M. E. Pokross, S. L. Posy, H. Shen, N. Surti, R. Talbott, Y. Zhang, N. K. Terrett; J. Med. Chem. 2015; 58(6): 2855–2861. https://doi.org/10.1021/jm501892g

Effective PHIP Labeling of Bioactive Peptides Boosts the Intensity of the NMR Signal; G. Sauer, D. Nasu, D. Tietze, T. Gutmann, S. Englert, O. Avrutina, H. Kolmar, G. Buntkowsky; Angew. Chem. Int. Ed. 2014, 53(47): 12941-12945. https://doi.org/10.1002/anie.201404668

Ultrafast Single-Scan 2D NMR Spectroscopic Detection of a PHIP-Hyperpolarized Protease Inhibitor; A. S. Kiryutin; G. Sauer, D. Tietze, M. Brodrecht, S. Knecht, A. V. Yurkovskaya, K. L. Ivanov, O. Avrutina, H. Kolmar, G. Buntkowsky; Chem.-Eur. J. 2019; 25(16): 4025-4030. https://doi.org/10.1002/chem.201900079

Conjugation Strategy Strongly Impacts the Conformational Stability of a PEG-Protein Conjugate; P. B. Lawrence, W. M. Billings, M. B. Miller, B. K. Pandey, A. R. Stephens, M. I. Langlois, J. L. Price; ACS Chem. Biol. 2016; 11(7): 1805–1809. https://doi.org/10.1021/acschembio.6b00349

In Vitro Membrane Permeation Studies and in Vivo Antinociception of Glycosylated Dmt1-DALDA Analogues; S. Ballet, C. Betti, A. Novoa, C. Tömböly, C. U. Nielsen, H. C. Helms, A. Lesniak, P. Kleczkowska, N. N. Chung, A. W. Lipkowski, B. Brodin, D. Tourwe, P. W. Schiller; ACS Med. Chem. Lett. 2014, 5(4): 352–357. https://doi.org/10.1021/ml4004765